6533b7d2fe1ef96bd125f0e4

RESEARCH PRODUCT

Terapia biologica con infliximab (anti-TNF) nella malattia di Crohn: analisi delle complicanze.

Antonio CarroccioLidia Di PrimaPirrone GGiuseppe AmbrosianoNoto DAngelo Baldassare Cefalu'

subject

Adverse eventCrohn diseaseTuberculosisInfliximab

description

Anti-tumor necrosis factor (anti-TNF) therapy is an important therapeutic addition in the treatment of active Crohn's disease. Although controlled trials have confirmed the efficacy of anti-TNF (infliximab) treatment, serious toxicities related to the therapies have emerged. The purpose of this article was to review the safety profile of infliximab, and in particular analyse the infectious complications, the autoimmune disorders and the theoretical risk of cancer and lymphoma

http://hdl.handle.net/10447/11963